Sopharma Trading AD (BUL:SFT)
Bulgaria · Delayed Price · Currency is BGN · Price in EUR 2.920
-0.020 (-0.68%)
At close: Jul 31, 2026
Sopharma Trading AD Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,212 | 1,173 | 1,000 | 858.14 | 757.95 | 683.08 |
Revenue Growth | 15.91% | 17.32% | 16.56% | 13.22% | 10.96% | 15.58% |
Gross Profit Gross Profit Growth | 164.1 | 160.48 | 128.01 | 100.21 | 87.99 | 72.79 |
Operating Income Operating Income Growth | 39.18 | 41.13 | 30.78 | 22.86 | 20.38 | 8.21 |
Net Income Net Income Growth | 26.48 | 29.71 | 20.64 | 14.93 | 4.64 | 4.12 |
Earnings Per Share EPS Growth | 0.78 | 0.87 | 0.60 | 0.44 | 0.14 | 0.12 |
EPS Growth | 3.16% | 44.88% | 38.41% | 221.74% | 12.75% | -29.83% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Sale of Pharmaceutical and Medical Products Sale of Pharmaceutical and Medical Products Growth | 1,188 | 1,151 | 975.23 | 845.05 | 748.69 | 674.03 |
Medical Equipment Medical Equipment Growth | - | 15.98 | 20.17 | 10.5 | 7.08 | 9.05 |
Total Total Growth | 1,205 | 1,167 | 995.4 | 855.56 | 755.77 | 683.08 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 7.37 | 7.86 | 7.01 | 6.7 | 3.49 | 5.98 |
Total Debt Total Debt Growth | 175.74 | 178.35 | 142.22 | 128.75 | 129.59 | 138.56 |
Net Cash (Debt) Net Cash Growth | -168.37 | -170.49 | -135.21 | -122.05 | -126.1 | -132.58 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -4.95 | -5.01 | -3.95 | -3.56 | -3.68 | -3.87 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 15.8 | -2.16 | 35.31 | 24.52 | 9.5 | -88.39 |
Capital Expenditures CapEx Growth | -9.04 | -8.61 | -7.3 | -5.28 | -2.93 | -3.85 |
Free Cash Flow Free Cash Flow Growth | 6.76 | -10.77 | 28.01 | 19.24 | 6.56 | -92.24 |
Free Cash Flow Growth | -70.03% | - | 45.57% | 193.07% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 13.54% | 13.68% | 12.80% | 11.68% | 11.61% | 10.66% |
Operating Margin | 3.23% | 3.50% | 3.08% | 2.66% | 2.69% | 1.20% |
Pretax Margin | 2.65% | 3.05% | 2.41% | 2.04% | 0.84% | 0.71% |
Profit Margin | 2.18% | 2.53% | 2.06% | 1.74% | 0.61% | 0.60% |
FCF Margin | 0.56% | -0.92% | 2.80% | 2.24% | 0.87% | -13.50% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 3.75 | 3.38 | 4.93 | 7.04 | 22.65 | 22.35 |
Forward PE | - | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 |
P/FCF Ratio | 14.77 | - | 3.64 | 5.47 | 16.01 | - |
PS Ratio | 0.08 | 0.09 | 0.10 | 0.12 | 0.14 | 0.14 |